Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population.

Molecular biology reports - 1 Sept 2008

Shammaa Dina M R, Sabbagh Amira S, Taher Ali T, Zaatari Ghazi S, Mahfouz Rami A R

Abstract excerpt

Plasminogen activator inhibitor-1 (PAI-1) is an inhibitor of fibrinolysis. Increased plasma PAI-1 levels play an essential role in the pathogenesis of cardiovascular risk and other diseases associated with thrombosis. The 4G/5G polymorphism of the PAI-1 promoter region has been extensively studied in different populations. We studied 160 healthy unrelated Lebanese individuals using a reverse hybridization PCR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Genotype
Share to Lebanon

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Plasminogen Activator Inhibitor 1

Source

Identifiers

PMID: 17578681
DOI: 10.1007/s11033-007-9106-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population.PMID 17578681Read ↗

Frequency distribution of the G/A alleles of the beta-fibrinogen gene in the Lebanese population.Semantic proximity Read ↗

Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in the Turkish population.Semantic proximity Read ↗

Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.Semantic proximity Read ↗

The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian PopulationSemantic proximity Read ↗

Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.Semantic proximity Read ↗

Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.Semantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis.Semantic proximity Read ↗

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolismSemantic proximity Read ↗

The Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and the Risk of Alzheimer's Disease.Semantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.Semantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosisSemantic proximity Read ↗

The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic riskSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.